“…Focusing on the main stress pathway (HPA axis and SNS), chronic administration of corticosteroid or hypercortisolism (e.g., Cushing's syndrome) enhanced plasma levels of vWF, PAI-1 and FVIII levels, and decreased markers of fibrinolytic activation [50,[97][98][99][100][101][102]. Similarly, the administration of glucocorticoids in healthy subjects increased levels of fibrinogen and vWF [50,[101][102][103], whereas during active inflammation, there were increased levels of PAI-1 but concomitantly decreased levels of VWF and fibrinogen [104], reducing inflammation and the pulmonary embolism in trauma patients [105]. F, factor; a, clotting activity; ag, antigen; vWF, von Willebrand Factor; TAT, thrombin-antithrombin complex; PT, prothrombin time; aPTT, activated partial thromboplastin time; t-PA, tissue-plasminogen activator; PAI-1, plasminogen activator inhibitor-1.…”